Yorkville Advisors — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
PDS BiotechnologyNASDAQ: PDSBJun 2026
NASDAQ-listed company harnessing immunology for therapeutic development
BiotechNorth Brunswick, US
Frank K. Bedu-Addo(Executive Officer)
Co-investorsEMV Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.